Related Experiment Video
Updated: Jun 10, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study
Søren J Nielsen1, Jørgen Jeppesen, Christian Torp-Pedersen
1Department of Medicine, Copenhagen University Hospital, Glostrup, Denmark.
American Journal of Hypertension
|August 14, 2010
Summary
A common genetic variation in the tyrosine hydroxylase (TH) gene promoter is linked to higher blood pressure and increased hypertension risk in the general population. This single nucleotide polymorphism (SNP) influences sympathetic nervous system activity.
Area of Science:
- Genetics and cardiovascular health
- Sympathetic nervous system function
- Hypertension research
Background:
- Sympathetic nervous system (SNS) overactivity is common in hypertension and may precede its development.
- Tyrosine hydroxylase (TH) gene promoter variations can affect SNS traits and blood pressure.
Purpose of the Study:
- To investigate the association between a specific single-nucleotide polymorphism (SNP) in the TH promoter (C-824T) and blood pressure (BP).
- To analyze this relationship in a large, diverse general population sample using 24-h ambulatory BP monitoring and office BP measurements.
Main Methods:
- Genotyping of the C-824T single-nucleotide polymorphism (SNP) in the TH promoter.
- Measurement of 24-h ambulatory blood pressure (ABP) and office blood pressure (BP).
- Statistical analysis of genotype-phenotype correlations in 2,403 participants (ages 41-71).
Main Results:
- The T/T genotype of the C-824T SNP was associated with a ~45% increased relative risk of hypertension compared to the C/C genotype.
- Participants with the T/T genotype exhibited significantly higher mean systolic BP (138 mmHg vs. 135 mmHg), diastolic BP (88 mmHg vs. 85 mmHg), and heart rate (68 bpm vs. 66 bpm).
- Intermediate BP and heart rate values were observed in the C/T genotype group, with consistent findings across genders and BP measurement methods.
Conclusions:
- The C-824T single-nucleotide polymorphism (SNP) in the proximal TH promoter is a significant determinant of blood pressure and hypertension prevalence.
- This genetic variation in the tyrosine hydroxylase gene impacts cardiovascular risk factors in the general population.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:28Hypertension I: Introduction
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...